FdaApplication
NDA 210064
Identifiers
- fda_app_no: NDA210064
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA |
| application_type | NDA |
| approval_date | 2019-09-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product